Form 8-K - Current report:
SEC Accession No. 0001437749-25-027191
Filing Date
2025-08-18
Accepted
2025-08-18 09:29:35
Documents
13
Period of Report
2025-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20250815_8k.htm   iXBRL 8-K 33555
  Complete submission text file 0001437749-25-027191.txt   169314

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250818.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250818_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250818_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250818_pre.xml EX-101.PRE 12022
15 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250815_8k_htm.xml XML 2933
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)